Enterococcus faecalis
Enterococcus faecalis is a species of bacteria that is often found in the human gastrointestinal tract. It is a Gram-positive, coccus-shaped bacterium that is part of the Enterococcus genus.
Characteristics[edit]
Enterococcus faecalis is facultatively anaerobic, meaning it can grow in both the presence and absence of oxygen. It is also halotolerant, able to survive in high salt concentrations, and can grow at temperatures ranging from 10 to 45 degrees Celsius.
Pathogenicity[edit]
While Enterococcus faecalis is a normal part of the human gut flora, it can also be a cause of disease. It is a common cause of urinary tract infections and bacteremia, and can also cause endocarditis and meningitis. Its ability to form biofilms contributes to its pathogenicity, as this can protect the bacteria from the host's immune response and from antibiotics.
Antibiotic Resistance[edit]
Enterococcus faecalis is known for its high level of antibiotic resistance. It is naturally resistant to many antibiotics, including aminoglycosides, and can acquire resistance to others through horizontal gene transfer. This has led to the emergence of multidrug-resistant strains, which are a significant concern in healthcare settings.
Treatment[edit]
Treatment of infections caused by Enterococcus faecalis can be challenging due to its antibiotic resistance. However, certain antibiotics, such as ampicillin, vancomycin, and linezolid, are often effective. In cases of multidrug-resistant infections, combination therapy may be used.
See Also[edit]
-
Enterococcus faecalis under microscope
-
Enterococcus faecalis culture
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian